Clearside Biomedical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CLSD and other ETFs, options, and stocks.

About CLSD

Clearside Biomedical, Inc. is a biopharmaceutical company, which delivers therapies to the back of the eye through the suprachoroidal space. Its pipeline include CLS-AX, Integrin Inhibitor, and gene therapy. 

CEO
George M. Lasezkay
CEOGeorge M. Lasezkay
Employees
30
Employees30
Headquarters
Alpharetta, Georgia
HeadquartersAlpharetta, Georgia
Founded
2011
Founded2011
Employees
30
Employees30

CLSD Key Statistics

Market cap
97.88M
Market cap97.88M
Price-Earnings ratio
-2.49
Price-Earnings ratio-2.49
Dividend yield
—
Dividend yield—
Average volume
162.31K
Average volume162.31K
High today
$1.35
High today$1.35
Low today
$1.26
Low today$1.26
Open price
$1.34
Open price$1.34
Volume
98.53K
Volume98.53K
52 Week high
$2.12
52 Week high$2.12
52 Week low
$0.6501
52 Week low$0.6501

CLSD News

Yahoo Finance 4d
Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May ... - Yahoo Finance

Clearside Biomedical, Inc. ALPHARETTA, Ga., April 30, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutio...

Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May ... - Yahoo Finance
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.